medical device investing T2 Biosystems Expands Rapid Diagnostic Technologies to Australia, Fiji and New Zealand
New Data Suggests T2 Biosystems’ T2Lyme Panel is More Accurate than Other Diagnostics for Identifying Borrelia Infections for Patients Suspected of Having Early Lyme Disease
medical device investing T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update
NextSource Materials Signs Agreement for the Supply of Graphite Fines as Additional Source of Feedstock for its Battery Anode Facility in Abu Dhabi
